-
Mitochondrial Potential as a Translational Immune Readout
2026-09-02
Mitochondrial membrane potential can convert mechanistic hypotheses about redox stress and immunogenic tumor cell death into a measurable translational endpoint. This thought-leadership guide shows how to position JC-1 ratiometric analysis alongside TrxR/MAPK biology, apoptosis assays, and immune phenotyping without overinterpreting depolarization as proof of clinical efficacy.
-
GSDMC Rewires PDAC Stemness and Immune Evasion
2026-09-01
A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a nuclear regulator of pancreatic ductal adenocarcinoma rather than solely a pyroptosis-associated pore-forming protein. The work links ADAM17-dependent GSDMC cleavage to stemness, metastasis, CXCL9-controlled immune exclusion, and improved responses to KRASG12D inhibition and PD-1 blockade in preclinical models.
-
Toremifene for Breast Cancer: 20 Years of Evidence
2026-08-31
This review synthesizes two decades of clinical and pharmacologic evidence for toremifene, an oral selective estrogen receptor modulator, in postmenopausal estrogen receptor-positive breast cancer. Its main contribution is a balanced interpretation of efficacy, safety, tissue-selective activity, and pharmacokinetic differences from tamoxifen, helping researchers and clinicians place toremifene within individualized endocrine therapy.
-
Nelfinavir Mesylate: From HIV to Ferroptosis
2026-08-31
Nelfinavir Mesylate is an HIV-1 protease inhibitor with a well-defined antiviral mechanism and emerging value in ferroptosis research. This article explains how to separate validated HIV pharmacology from exploratory DDI2–NFE2L1 assay interpretation.
-
Mitomycin C as an ICL-Repair Assay Probe
2026-08-30
Mitomycin C is more than a cytotoxic DNA synthesis inhibitor: it can serve as a strategic probe of interstrand crosslink repair. This article connects its assay use to ERCC1 and p53 biology, clarifying controls, readouts, and interpretation limits for cancer research.
-
Cy3-UTP Workflows for Fluorescent RNA Assays
2026-08-29
Cy3-UTP enables sequence-defined fluorescent RNA for spatial imaging, condensate reconstitution, and RNA-protein interaction studies. This guide connects practical in vitro transcription RNA labeling with assays inspired by replication-organelle clustering and provides optimization steps for signal, RNA function, and reproducibility.
-
Cabazitaxel (XRP6258): Practical Lab Guide
2026-08-29
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble semi-synthetic taxane derivative for studying antiproliferative responses and microtubule dynamics disruption, including workflows involving P-glycoprotein-expressing or taxane-resistant cancer cells. It should be handled in DMSO or ethanol, used promptly after solution preparation, and excluded from water-based assays unless a separately validated formulation is available.
-
Amphotericin B: From Membrane Pores to Translation
2026-08-28
A mechanism-driven framework for using Amphotericin B in fungal infection research, immune-signaling assays, translational model design, and reproducible workflow development.
-
5-Aminolevulinic acid HCl and Heme-Driven Virulence
2026-08-28
Recent Salmonella research reveals that regulated haem biosynthesis can shape macrophage phagocytosis and pathogen fitness. This thought-leadership analysis positions 5-Aminolevulinic acid HCl as a strategic pathway-perturbation reagent for testing precursor rescue, metabolic plasticity, and translational links between infection biology and porphyrin-based cancer research.
-
Chuanxiong Cortex, Pith, and Fenipentol in CHD
2026-08-27
The reference study combines SPME-GC×GC-MS with network pharmacology and molecular docking to distinguish the volatile chemistry and predicted coronary heart disease relevance of Chuanxiong rhizome cortex and pith. Its main contribution is a tissue-resolved framework that places Fenipentol among the prominent cortex-associated constituents while separating analytical identification from mechanistic validation.
-
MLKL Polymerization and Lysosomal Permeabilization
2026-08-27
The reference study identifies lysosomal membrane permeabilization as a critical execution step in necroptosis driven by polymerized MLKL. Through live-cell imaging and CTSB perturbation, it shows that MLKL-dependent lysosomal damage releases cathepsin B before plasma membrane rupture, thereby linking necrosome activation to proteolytic loss of cell survival machinery.
-
NVP-BGJ398 phosphate in Viability Assays
2026-08-26
Learn how NVP-BGJ398 phosphate, SKU A3673, can improve the design and interpretation of FGFR-dependent cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers mechanism, dose selection, formulation, cross-domain applications, and practical vendor-selection criteria.
-
Proteinase K: From DNA Cleanup to Protease Strategy
2026-08-26
Proteinase K is more than a routine digestion reagent: its broad substrate tolerance, nuclease-removal utility, and performance across DNA isolation conditions make it a strategic tool for translational workflow design and protease assay control.
-
BRCA2, PARP1 Retention and RAD51 Filament Protection
2026-08-25
The reference study identifies a direct mechanism linking PARP inhibitor-induced PARP1 retention to destabilization of RAD51 filaments on resected DNA. Its biochemical, single-molecule, and cellular data show that full-length BRCA2 protects homologous-recombination repair sites by limiting PARP1 binding, clarifying why BRCA2-deficient tumors can be especially vulnerable to PARP inhibition.
-
Cardiogreen: Imaging, PDT, and Assay Design
2026-08-25
Cardiogreen (Indocyanine green) connects vascular diagnostics with light-activated cell assays, including photodynamic therapy and emerging tumor-immunology workflows. This guide translates its spectral properties into practical preparation, controls, troubleshooting, and evidence-aligned experimental choices.
451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page